Related Experiment Video

Updated: May 9, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Is colchicine therapy effective in all patients with secondary amyloidosis?

Selman Unverdi1, Salih Inal, Mevlut Ceri

  • 1Department of Nephrology, Ankara Educational and Training Hospital, Ankara, Turkey. selmanunverdi@yahoo.com

Renal Failure
|July 12, 2013
PubMed
Abstract

Insights

Colchicine therapy is more effective for reducing proteinuria in early-stage renal amyloidosis. However, patients with rheumatoid disorder-associated amyloidosis showed limited response to colchicine treatment.

Area of Science:

  • Nephrology
  • Rheumatology
  • Pharmacology

Background:

  • Amyloidosis is a condition characterized by the buildup of amyloid protein deposits in organs.
  • Colchicine is a medication used to treat and prevent amyloidosis, but its effectiveness varies.
  • Factors influencing colchicine response in amyloidosis require further investigation.

Purpose of the Study:

  • To evaluate the effectiveness of colchicine therapy in patients with renal amyloidosis.
  • To identify factors associated with colchicine response, specifically proteinuria reduction and glomerular filtration rate (GFR) changes.
  • To compare treatment outcomes based on proteinuria levels and amyloidosis etiology.

Main Methods:

  • A study included 24 patients with renal amyloidosis, categorized by proteinuria (non-nephrotic vs. nephrotic) and etiology (familial Mediterranean fever [FMF]-associated vs. rheumatoid disorder [RD]-associated).
  • Changes in proteinuria and GFR were monitored after initiating colchicine treatment.
  • Statistical analysis compared outcomes between patient subgroups.

Main Results:

  • Colchicine therapy led to a significant proteinuria decrease in 78% of non-nephrotic patients, while 50% of nephrotic patients experienced increased proteinuria.
  • GFR remained stable in both nephrotic and non-nephrotic groups.
  • Patients with FMF-associated amyloidosis showed significant proteinuria reduction, unlike those with RD-associated amyloidosis.

Conclusions:

  • Colchicine is more effective in the non-nephrotic (low proteinuric) stage of renal amyloidosis.
  • Colchicine therapy demonstrated limited benefit for patients with RD-associated amyloidosis.

More Related Videos

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...